BioWorld

Oct. 24, 2002

Pfizer Claims Lilly, GSK, Bayer, ICOS Violate Viagra Patent

Lilly ICOS LLC said it intends to "vigorously defend itself" against a claim by Pfizer Inc. that its erectile dysfunction candidate, Cialis, infringes on Pfizer's patent that protects the blockbuster drug, Viagra. (BioWorld Today) Read More

Biovitrum Signs $150M Deal With Glaxo For Obesity Drug

Old Age Macular Degeneration Looks To Proteomics For Cures By Controlling Drusen Proteins

Cephalon's Provigil Positive In Shift-Work Sleep Disorder

Other News To Note

Amgen Submits Bid To Expand Kineret Label For RA Damage

Appointments And Advancements

Today's news in brief

BioWorld

BioWorld briefs for Jan 23, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 23, 2026.

Illustration of magnifying glass inspecting brain

Neurotrimin unveiled as marker in intellectual disability

BioWorld Science

Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...

DNA mutations or genetic disorder concept art

Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

BioWorld Science

Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...